Rovista®EZ is a combination of rosuvastatin, an HMG CoA-reductase inhibitor (statin), and ezetimibe, a dietary cholesterol absorption inhibitor, indicated:

• as an adjunct to diet in patients with primary (heterozygous familial and non-familial) hyperlipidemia to reduce low-density lipoprotein cholesterol (LDL-C)
• alone or as an adjuct to other LDL-C lowering therapies in patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C